Cargando…
ACMT Position Statement: Off-Label Prescribing during COVID-19 Pandemic
Autores principales: | Stolbach, Andrew I., Mazer-Amirshahi, Maryann, Marino, Ryan, Nelson, Lewis S., Sugarman, Jeremy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272106/ https://www.ncbi.nlm.nih.gov/pubmed/32500283 http://dx.doi.org/10.1007/s13181-020-00784-6 |
Ejemplares similares
-
ACMT Position Statement: Medication Shortages During Coronavirus Disease Pandemic
por: Mazer-Amirshahi, Maryann, et al.
Publicado: (2020) -
ACMT Position Statement: Caring for Patients with Opioid Use Disorder during Coronavirus Disease Pandemic
por: Stolbach, Andrew, et al.
Publicado: (2020) -
ACMT Position Statement: Medication Administration and Safety During the Response to COVID-19 Pandemic
por: Farmer, Brenna M., et al.
Publicado: (2020) -
American College of Medical Toxicology (ACMT) Cautions Against Off-Label Prescribing of Ivermectin for the Prevention or Treatment of COVID-19
por: Calello, Diane P., et al.
Publicado: (2022) -
Position Statements
Publicado: (2009)